Trexquant Investment LP raised its holdings in Masimo Co. (NASDAQ:MASI) by 298.2% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 19,627 shares of the medical equipment provider’s stock after purchasing an additional 14,698 shares during the quarter. Trexquant Investment LP’s holdings in Masimo were worth $2,444,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also modified their holdings of the company. Northwestern Mutual Wealth Management Co. bought a new position in Masimo in the 2nd quarter valued at $109,000. US Bancorp DE raised its position in Masimo by 36.9% in the 2nd quarter. US Bancorp DE now owns 1,980 shares of the medical equipment provider’s stock valued at $193,000 after purchasing an additional 534 shares during the last quarter. BancorpSouth Bank bought a new position in Masimo in the 2nd quarter valued at $212,000. CIBC Asset Management Inc bought a new position in Masimo in the 3rd quarter valued at $227,000. Finally, Parametrica Management Ltd bought a new position in Masimo in the 3rd quarter valued at $234,000. Hedge funds and other institutional investors own 88.00% of the company’s stock.
MASI has been the subject of several research analyst reports. Stifel Nicolaus lifted their price objective on Masimo from $112.00 to $145.00 and gave the company a “buy” rating in a research report on Tuesday, October 2nd. BidaskClub downgraded Masimo from a “buy” rating to a “hold” rating in a research report on Tuesday, November 13th. Zacks Investment Research cut Masimo from a “buy” rating to a “hold” rating in a research note on Friday, November 16th. Piper Jaffray Companies lifted their target price on Masimo to $120.00 and gave the company a “neutral” rating in a research note on Thursday, November 1st. Finally, Needham & Company LLC assumed coverage on Masimo in a research note on Friday, September 14th. They issued a “buy” rating for the company. Three analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $114.40.
In other news, CEO Joe E. Kiani sold 239,926 shares of Masimo stock in a transaction on Tuesday, September 4th. The stock was sold at an average price of $117.95, for a total value of $28,299,271.70. Following the completion of the sale, the chief executive officer now directly owns 236,061 shares of the company’s stock, valued at approximately $27,843,394.95. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Sanford Fitch sold 2,000 shares of Masimo stock in a transaction on Thursday, November 1st. The shares were sold at an average price of $113.14, for a total value of $226,280.00. The disclosure for this sale can be found here. Insiders sold a total of 666,033 shares of company stock valued at $79,900,568 over the last three months. Insiders own 12.60% of the company’s stock.
NASDAQ MASI opened at $102.97 on Monday. The firm has a market capitalization of $5.46 billion, a PE ratio of 42.03, a PEG ratio of 2.42 and a beta of 1.11. Masimo Co. has a 52 week low of $80.69 and a 52 week high of $126.89.
Masimo (NASDAQ:MASI) last released its earnings results on Wednesday, October 31st. The medical equipment provider reported $0.71 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.69 by $0.02. The company had revenue of $210.58 million during the quarter, compared to analysts’ expectations of $207.62 million. Masimo had a return on equity of 20.29% and a net margin of 17.08%. The business’s revenue for the quarter was up 8.9% on a year-over-year basis. During the same period last year, the firm earned $0.56 EPS. Sell-side analysts predict that Masimo Co. will post 2.92 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION WARNING: “Masimo Co. (MASI) Shares Bought by Trexquant Investment LP” was originally posted by Transcript Daily and is the sole property of of Transcript Daily. If you are accessing this story on another publication, it was illegally copied and republished in violation of U.S. & international trademark and copyright legislation. The correct version of this story can be viewed at https://transcriptdaily.com/2018/11/26/masimo-co-masi-shares-bought-by-trexquant-investment-lp.html.
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.
Featured Article: New Google Finance Tool and Screening Stocks
Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASI).
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.